+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
AI for Clinical & Molecular Diagnostics Market - Global Forecast 2025-2030- Product Image
AI for Clinical & Molecular Diagnostics Market - Global Forecast 2025-2030- Product Image
Sale

AI for Clinical & Molecular Diagnostics Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 180 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6120598
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Artificial intelligence is driving fundamental change in clinical and molecular diagnostics, streamlining laboratory operations, improving diagnostic accuracy, and enabling more personalized treatment options. With the integration of machine learning, data analytics, and automation, industry leaders across the healthcare value chain are redefining how disease detection and therapy planning are approached.

Market Snapshot: Clinical & Molecular Diagnostics Powered by Artificial Intelligence

The global clinical and molecular diagnostics market is experiencing accelerated growth, fueled by advances in AI technology and an expanding need for streamlined, precise diagnostic solutions. Senior decision-makers are navigating shifting landscapes in disease screening, assay development, and data-driven healthcare delivery, positioning their organizations to benefit from rapid innovations and evolving regulatory outlooks. As laboratories and research institutions adopt AI-driven platforms, the competitive environment is being reset by smarter workflows, adaptive supply chains, and new service delivery modes.

Scope & Segmentation

This report comprehensively analyzes the market by product type, technology, application, end user, test setting, and region, with segmentation ensuring actionable insights for a variety of strategic requirements.

  • Product Type: Consumables & reagents such as enzymes, high purity reagents, kits & assays; instruments & systems including mass spectrometry systems, microarray scanners, PCR instruments, sequencers; platforms & software like bioinformatics platforms, data management and instrument control software; service offerings including installation & maintenance, outsourced testing services, training & support.
  • Technology: Mass spectrometry (liquid chromatography mass spectrometry, MALDI-TOF), microarray (gene expression arrays, SNP arrays), next-generation sequencing technologies (RNA sequencing, targeted and whole genome sequencing), and polymerase chain reaction methods (digital PCR, real-time PCR).
  • Application: Genetic disease screening, infectious disease diagnostics for bacterial and viral pathogens, oncology (liquid biopsy, solid tumor testing), pharmacogenomics, and prenatal testing.
  • End User: Academic institutions, diagnostic laboratories, hospitals & clinics, pharmaceutical firms, and research institutes.
  • Test Setting: Central laboratory, field testing, home healthcare, point of care environments.
  • Regions Covered: Americas (including the United States, Canada, Mexico, Brazil, Argentina, among others), Europe, Middle East & Africa (e.g., UK, Germany, France, UAE, South Africa), and Asia-Pacific (e.g., China, India, Japan, South Korea, Australia).

Key Takeaways for Senior Decision-Makers

  • Artificial intelligence integrates advanced analytics with laboratory workflows, resulting in greater assay sensitivity, reduced turnaround times, and enhanced process standardization.
  • AI-enabled pattern recognition is rapidly being adopted in high-resolution imaging and multi-omics data analysis, unlocking new frontiers in predictive and preventive healthcare models.
  • Healthcare ecosystems are witnessing a transition to decentralized and remote testing modalities, empowered by remote monitoring and on-site analysis through intelligent platforms.
  • Regulatory frameworks are adapting, with evolving guidance on algorithm validation and ongoing performance monitoring, prompting organizations to carefully align compliance strategies with innovation goals.
  • Supply chain pressures—including 2025 U.S. tariffs on key reagents, components, and software licenses—are prompting manufacturers and service providers to rethink supplier diversity and local production, impacting both cost structures and resilience.
  • Competitive differentiation is increasingly achieved via integrated, open ecosystem architectures and scalable AI infrastructure, as industry leaders pursue partnerships, alliances, and targeted acquisitions.

Tariff Impact: Navigating 2025 Supply Chain Disruptions

The imposition of United States tariffs in 2025 on critical reagents, instrumentation components, and software has introduced new cost dynamics and logistical complexities for diagnostic manufacturers and service providers. In response, organizations are strengthening inventory buffers, diversifying supplier networks, and investing in local production capabilities. Innovation in reagent design and instrument modularity is accelerating as companies seek to reduce reliance on tariff-exposed elements. AI-powered procurement and resource allocation tools are being leveraged to optimize inventory decisions and maintain market agility.

Methodology & Data Sources

The analysis draws on a rigorous blend of primary expert interviews with clinicians, AI specialists, and laboratory leaders, combined with reviews of manufacturer documentation, regulatory filings, industry publications, and survey-based quantitative data. Data triangulation and geospatial scenario modeling provide a robust foundation for insights, supporting strategic planning under evolving regulatory and market conditions.

Why This Report Matters

  • Enables decision-makers to benchmark diagnostic innovation, AI integration, and operational optimization strategies against regional and global leaders.
  • Delivers critical guidance for navigating regulatory changes, supply chain disruptions, and technology rollouts, aligning investments with high-impact opportunities.
  • Equips organizations to identify emerging partnership, acquisition, and market entry strategies, tailoring approaches to distinctive sector, technology, and regional requirements.

Conclusion

AI is actively shaping the future of clinical and molecular diagnostics, providing a foundation for more accurate, efficient, and patient-centric healthcare. Strategic adoption, robust infrastructure, and adaptive compliance approaches are central to sustained success in this evolving market.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Integration of deep learning algorithms for early cancer detection from histopathology images
5.2. Development of AI-driven multiplex genomic assays for personalized therapy decision support
5.3. Adoption of federated learning models to protect patient data privacy in molecular diagnostics
5.4. Utilization of natural language processing to automate clinical trial eligibility screening
5.5. Implementation of real-time AI analysis pipelines for rapid infectious disease outbreak monitoring
5.6. Advances in transformer-based architectures for comprehensive multi-omics data interpretation
5.7. Application of machine learning risk scores for predicting patient response to immunotherapy treatments
5.8. Deployment of explainable AI frameworks to increase clinician trust in diagnostic test outputs
5.9. Integration of AI-enabled digital pathology platforms with laboratory information management systems
5.10. Use of AI-guided biomarker discovery to accelerate development of companion diagnostics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. AI for Clinical & Molecular Diagnostics Market, by Product Type
8.1. Introduction
8.2. Consumables & Reagents
8.2.1. Enzymes
8.2.2. High Purity Reagents
8.2.3. Kits & Assays
8.3. Instruments & Systems
8.3.1. Mass Spectrometry Systems
8.3.2. Microarray Scanners
8.3.3. PCR Instruments
8.3.4. Sequencers
8.4. Platforms & Software
8.4.1. Bioinformatics Platforms
8.4.2. Data Management Software
8.4.3. Instrument Control Software
8.5. Services
8.5.1. Installation & Maintenance
8.5.2. Outsourced Testing Services
8.5.3. Training & Support
9. AI for Clinical & Molecular Diagnostics Market, by Technology
9.1. Introduction
9.2. Mass Spectrometry
9.2.1. Liquid Chromatography Mass Spectrometry
9.2.2. MALDI-TOF
9.3. Microarray
9.3.1. Gene Expression Arrays
9.3.2. SNP Arrays
9.4. Next-Generation Sequencing
9.4.1. RNA Sequencing
9.4.2. Targeted Sequencing
9.4.3. Whole Genome Sequencing
9.5. Polymerase Chain Reaction
9.5.1. Digital PCR
9.5.2. Real-Time PCR
10. AI for Clinical & Molecular Diagnostics Market, by Application
10.1. Introduction
10.2. Genetic Disease
10.3. Infectious Disease
10.3.1. Bacterial Infection Testing
10.3.2. Viral Infection Testing
10.4. Oncology
10.4.1. Liquid Biopsy
10.4.2. Solid Tumor Testing
10.5. Pharmacogenomics
10.6. Prenatal Testing
11. AI for Clinical & Molecular Diagnostics Market, by End User
11.1. Introduction
11.2. Academic Institutions
11.3. Diagnostic Laboratories
11.4. Hospitals & Clinics
11.5. Pharmaceutical Companies
11.6. Research Institutes
12. AI for Clinical & Molecular Diagnostics Market, by Test Setting
12.1. Introduction
12.2. Central Laboratory
12.3. Field Testing
12.4. Home Healthcare
12.5. Point of Care
13. Americas AI for Clinical & Molecular Diagnostics Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa AI for Clinical & Molecular Diagnostics Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific AI for Clinical & Molecular Diagnostics Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. F. Hoffmann-La Roche Ltd
16.3.2. Abbott Laboratories
16.3.3. Siemens Healthineers AG
16.3.4. Danaher Corporation
16.3.5. Thermo Fisher Scientific Inc.
16.3.6. Illumina, Inc.
16.3.7. QIAGEN N.V.
16.3.8. Agilent Technologies, Inc.
16.3.9. BioMérieux SA
16.3.10. General Electric Company
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 8. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY TEST SETTING, 2024 VS 2030 (%)
FIGURE 14. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY TEST SETTING, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET: RESEARCHAI
FIGURE 26. AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET: RESEARCHSTATISTICS
FIGURE 27. AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET: RESEARCHCONTACTS
FIGURE 28. AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & REAGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & REAGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY ENZYMES, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY ENZYMES, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY HIGH PURITY REAGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY HIGH PURITY REAGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY KITS & ASSAYS, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY KITS & ASSAYS, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & REAGENTS, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & REAGENTS, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS & SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS & SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY MASS SPECTROMETRY SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY MASS SPECTROMETRY SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY MICROARRAY SCANNERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY MICROARRAY SCANNERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY PCR INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY PCR INSTRUMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY SEQUENCERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY SEQUENCERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS & SYSTEMS, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS & SYSTEMS, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY PLATFORMS & SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY PLATFORMS & SOFTWARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY BIOINFORMATICS PLATFORMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY BIOINFORMATICS PLATFORMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY DATA MANAGEMENT SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY DATA MANAGEMENT SOFTWARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY INSTRUMENT CONTROL SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY INSTRUMENT CONTROL SOFTWARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY PLATFORMS & SOFTWARE, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY PLATFORMS & SOFTWARE, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY INSTALLATION & MAINTENANCE, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY INSTALLATION & MAINTENANCE, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY OUTSOURCED TESTING SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY OUTSOURCED TESTING SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY TRAINING & SUPPORT, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY TRAINING & SUPPORT, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY LIQUID CHROMATOGRAPHY MASS SPECTROMETRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY LIQUID CHROMATOGRAPHY MASS SPECTROMETRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY MALDI-TOF, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY MALDI-TOF, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY MASS SPECTROMETRY, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY MASS SPECTROMETRY, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY MICROARRAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY MICROARRAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY GENE EXPRESSION ARRAYS, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY GENE EXPRESSION ARRAYS, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY SNP ARRAYS, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY SNP ARRAYS, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY MICROARRAY, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY MICROARRAY, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY RNA SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY RNA SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY TARGETED SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY TARGETED SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY DIGITAL PCR, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY DIGITAL PCR, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY REAL-TIME PCR, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY REAL-TIME PCR, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY GENETIC DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY GENETIC DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY BACTERIAL INFECTION TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY BACTERIAL INFECTION TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY VIRAL INFECTION TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY VIRAL INFECTION TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY LIQUID BIOPSY, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY LIQUID BIOPSY, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY SOLID TUMOR TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY SOLID TUMOR TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY PHARMACOGENOMICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY PHARMACOGENOMICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRENATAL TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRENATAL TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 115. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 116. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 117. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 118. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 119. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 120. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 121. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 122. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 123. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 124. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 125. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY TEST SETTING, 2018-2024 (USD MILLION)
TABLE 126. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY TEST SETTING, 2025-2030 (USD MILLION)
TABLE 127. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY CENTRAL LABORATORY, BY REGION, 2018-2024 (USD MILLION)
TABLE 128. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY CENTRAL LABORATORY, BY REGION, 2025-2030 (USD MILLION)
TABLE 129. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY FIELD TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 130. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY FIELD TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 131. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 132. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 133. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY POINT OF CARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 134. GLOBAL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY POINT OF CARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 135. AMERICAS AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 136. AMERICAS AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 137. AMERICAS AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & REAGENTS, 2018-2024 (USD MILLION)
TABLE 138. AMERICAS AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & REAGENTS, 2025-2030 (USD MILLION)
TABLE 139. AMERICAS AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS & SYSTEMS, 2018-2024 (USD MILLION)
TABLE 140. AMERICAS AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS & SYSTEMS, 2025-2030 (USD MILLION)
TABLE 141. AMERICAS AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY PLATFORMS & SOFTWARE, 2018-2024 (USD MILLION)
TABLE 142. AMERICAS AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY PLATFORMS & SOFTWARE, 2025-2030 (USD MILLION)
TABLE 143. AMERICAS AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 144. AMERICAS AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 145. AMERICAS AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 146. AMERICAS AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 147. AMERICAS AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY MASS SPECTROMETRY, 2018-2024 (USD MILLION)
TABLE 148. AMERICAS AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY MASS SPECTROMETRY, 2025-2030 (USD MILLION)
TABLE 149. AMERICAS AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY MICROARRAY, 2018-2024 (USD MILLION)
TABLE 150. AMERICAS AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY MICROARRAY, 2025-2030 (USD MILLION)
TABLE 151. AMERICAS AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 152. AMERICAS AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 153. AMERICAS AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
TABLE 154. AMERICAS AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2030 (USD MILLION)
TABLE 155. AMERICAS AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 156. AMERICAS AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 157. AMERICAS AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2024 (USD MILLION)
TABLE 158. AMERICAS AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE, 2025-2030 (USD MILLION)
TABLE 159. AMERICAS AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 160. AMERICAS AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 161. AMERICAS AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 162. AMERICAS AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 163. AMERICAS AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY TEST SETTING, 2018-2024 (USD MILLION)
TABLE 164. AMERICAS AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY TEST SETTING, 2025-2030 (USD MILLION)
TABLE 165. AMERICAS AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 166. AMERICAS AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 167. UNITED STATES AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 168. UNITED STATES AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 169. UNITED STATES AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & REAGENTS, 2018-2024 (USD MILLION)
TABLE 170. UNITED STATES AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & REAGENTS, 2025-2030 (USD MILLION)
TABLE 171. UNITED STATES AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS & SYSTEMS, 2018-2024 (USD MILLION)
TABLE 172. UNITED STATES AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS & SYSTEMS, 2025-2030 (USD MILLION)
TABLE 173. UNITED STATES AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY PLATFORMS & SOFTWARE, 2018-2024 (USD MILLION)
TABLE 174. UNITED STATES AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY PLATFORMS & SOFTWARE, 2025-2030 (USD MILLION)
TABLE 175. UNITED STATES AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 176. UNITED STATES AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 177. UNITED STATES AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 178. UNITED STATES AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 179. UNITED STATES AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY MASS SPECTROMETRY, 2018-2024 (USD MILLION)
TABLE 180. UNITED STATES AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY MASS SPECTROMETRY, 2025-2030 (USD MILLION)
TABLE 181. UNITED STATES AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY MICROARRAY, 2018-2024 (USD MILLION)
TABLE 182. UNITED STATES AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY MICROARRAY, 2025-2030 (USD MILLION)
TABLE 183. UNITED STATES AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 184. UNITED STATES AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 185. UNITED STATES AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
TABLE 186. UNITED STATES AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2030 (USD MILLION)
TABLE 187. UNITED STATES AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 188. UNITED STATES AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 189. UNITED STATES AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2024 (USD MILLION)
TABLE 190. UNITED STATES AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE, 2025-2030 (USD MILLION)
TABLE 191. UNITED STATES AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 192. UNITED STATES AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 193. UNITED STATES AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 194. UNITED STATES AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 195. UNITED STATES AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY TEST SETTING, 2018-2024 (USD MILLION)
TABLE 196. UNITED STATES AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY TEST SETTING, 2025-2030 (USD MILLION)
TABLE 197. UNITED STATES AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 198. UNITED STATES AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 199. CANADA AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 200. CANADA AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 201. CANADA AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & REAGENTS, 2018-2024 (USD MILLION)
TABLE 202. CANADA AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & REAGENTS, 2025-2030 (USD MILLION)
TABLE 203. CANADA AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS & SYSTEMS, 2018-2024 (USD MILLION)
TABLE 204. CANADA AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS & SYSTEMS, 2025-2030 (USD MILLION)
TABLE 205. CANADA AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY PLATFORMS & SOFTWARE, 2018-2024 (USD MILLION)
TABLE 206. CANADA AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY PLATFORMS & SOFTWARE, 2025-2030 (USD MILLION)
TABLE 207. CANADA AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 208. CANADA AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 209. CANADA AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 210. CANADA AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 211. CANADA AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY MASS SPECTROMETRY, 2018-2024 (USD MILLION)
TABLE 212. CANADA AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY MASS SPECTROMETRY, 2025-2030 (USD MILLION)
TABLE 213. CANADA AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY MICROARRAY, 2018-2024 (USD MILLION)
TABLE 214. CANADA AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY MICROARRAY, 2025-2030 (USD MILLION)
TABLE 215. CANADA AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 216. CANADA AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 217. CANADA AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
TABLE 218. CANADA AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2030 (USD MILLION)
TABLE 219. CANADA AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 220. CANADA AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 221. CANADA AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2024 (USD MILLION)
TABLE 222. CANADA AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE, 2025-2030 (USD MILLION)
TABLE 223. CANADA AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 224. CANADA AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 225. CANADA AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 226. CANADA AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 227. CANADA AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY TEST SETTING, 2018-2024 (USD MILLION)
TABLE 228. CANADA AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY TEST SETTING, 2025-2030 (USD MILLION)
TABLE 229. MEXICO AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 230. MEXICO AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 231. MEXICO AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & REAGENTS, 2018-2024 (USD MILLION)
TABLE 232. MEXICO AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & REAGENTS, 2025-2030 (USD MILLION)
TABLE 233. MEXICO AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS & SYSTEMS, 2018-2024 (USD MILLION)
TABLE 234. MEXICO AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS & SYSTEMS, 2025-2030 (USD MILLION)
TABLE 235. MEXICO AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY PLATFORMS & SOFTWARE, 2018-2024 (USD MILLION)
TABLE 236. MEXICO AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY PLATFORMS & SOFTWARE, 2025-2030 (USD MILLION)
TABLE 237. MEXICO AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 238. MEXICO AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 239. MEXICO AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 240. MEXICO AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 241. MEXICO AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY MASS SPECTROMETRY, 2018-2024 (USD MILLION)
TABLE 242. MEXICO AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY MASS SPECTROMETRY, 2025-2030 (USD MILLION)
TABLE 243. MEXICO AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY MICROARRAY, 2018-2024 (USD MILLION)
TABLE 244. MEXICO AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY MICROARRAY, 2025-2030 (USD MILLION)
TABLE 245. MEXICO AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 246. MEXICO AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 247. MEXICO AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
TABLE 248. MEXICO AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2030 (USD MILLION)
TABLE 249. MEXICO AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 250. MEXICO AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 251. MEXICO AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2024 (USD MILLION)
TABLE 252. MEXICO AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE, 2025-2030 (USD MILLION)
TABLE 253. MEXICO AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 254. MEXICO AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 255. MEXICO AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 256. MEXICO AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 257. MEXICO AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY TEST SETTING, 2018-2024 (USD MILLION)
TABLE 258. MEXICO AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY TEST SETTING, 2025-2030 (USD MILLION)
TABLE 259. BRAZIL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 260. BRAZIL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 261. BRAZIL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & REAGENTS, 2018-2024 (USD MILLION)
TABLE 262. BRAZIL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & REAGENTS, 2025-2030 (USD MILLION)
TABLE 263. BRAZIL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS & SYSTEMS, 2018-2024 (USD MILLION)
TABLE 264. BRAZIL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS & SYSTEMS, 2025-2030 (USD MILLION)
TABLE 265. BRAZIL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY PLATFORMS & SOFTWARE, 2018-2024 (USD MILLION)
TABLE 266. BRAZIL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY PLATFORMS & SOFTWARE, 2025-2030 (USD MILLION)
TABLE 267. BRAZIL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 268. BRAZIL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 269. BRAZIL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 270. BRAZIL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 271. BRAZIL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY MASS SPECTROMETRY, 2018-2024 (USD MILLION)
TABLE 272. BRAZIL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY MASS SPECTROMETRY, 2025-2030 (USD MILLION)
TABLE 273. BRAZIL AI FOR CLINICAL & MOLECULAR DIAGNOSTICS MARKET SIZE, BY MICROARR

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this AI for Clinical & Molecular Diagnostics market report include:
  • F. Hoffmann-La Roche Ltd
  • Abbott Laboratories
  • Siemens Healthineers AG
  • Danaher Corporation
  • Thermo Fisher Scientific Inc.
  • Illumina, Inc.
  • QIAGEN N.V.
  • Agilent Technologies, Inc.
  • bioMérieux SA
  • General Electric Company

Related Topics

Related Reports

Fully Automatic Molecular Diagnostic System Market - Global Forecast 2025-2030 - Product Image

Fully Automatic Molecular Diagnostic System Market - Global Forecast 2025-2030

  • Report
  • 194 Pages
  • Global
From
Molecular Diagnostics Market - Global Forecast 2025-2030 - Product Image

Molecular Diagnostics Market - Global Forecast 2025-2030

  • Report
  • 187 Pages
  • Global
From
Molecular Diagnostics Market by Product & Service (Kits, Instruments, Software), Test Type (Lab, PoC), Sample (Blood, Urine), Technology (PCR, NGS, ISH), and Application (Infectious (Hepatitis, HIV, HAI, Flu), Cancer (Breast, Lung)) - Global Forecast to 2030 - Product Image

Molecular Diagnostics Market by Product & Service (Kits, Instruments, Software), Test Type (Lab, PoC), Sample (Blood, Urine), Technology (PCR, NGS, ISH), and Application (Infectious (Hepatitis, HIV, HAI, Flu), Cancer (Breast, Lung)) - Global Forecast to 2030

  • Report
  • 540 Pages
  • Global
From
Infectious Disease Molecular Diagnostics Market Report and Forecast 2025-2034 - Product Image

Infectious Disease Molecular Diagnostics Market Report and Forecast 2025-2034

  • Report
  • 350 Pages
  • Global
From
Molecular Diagnostics in Pharmacogenomics Market Size, Share & Trends Analysis Report by Product (Kits & Assays, Reagents, Services), by Therapeutic Area, by Technology, by Region, and Segment Forecasts, 2025-2033 - Product Image

Molecular Diagnostics in Pharmacogenomics Market Size, Share & Trends Analysis Report by Product (Kits & Assays, Reagents, Services), by Therapeutic Area, by Technology, by Region, and Segment Forecasts, 2025-2033

  • Report
  • 150 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.